Knockdown experiments using siRNA against RRM1 or RRM2 in ACC cell lines have shown reduced cell proliferation, increased apoptosis, and heightened sensitivity to chemotherapeutic agents [112]. Here, RRM1 is linked to adrenal cortex carcinoma.